Metraipolis › archive › dc_7818f5bfec01

Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42404549
DOI
10.1016/j.esmogo.2025.100270
License (as archived)
solo-consultazione
Archived
2026-11-07T23:46:40.275Z
SHA-256 of the archived text
7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004
Stable URL of this page
https://metraipolis.com/documento/dc_7818f5bfec01

How to cite

Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549 — Europe PMC (en), https://europepmc.org/article/MED/42404549 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7818f5bfec01 (Metraipolis archive dc_7818f5bfec01, sha256 7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004)
BibTeX
@misc{dc7818f5bfec01,
  title = {Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm… — Europe PMC PMID:42404549},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42404549},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7818f5bfec01; sha256 7b4875e19d1b7d867d7403f67127a8ab150f01a458e63255c1f19ae51d76a004},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42404549. Agents can read the archived copy with the MCP tool read_document.